Simplifying Global Compliance
GMPs: FDA Looked Beyond U.S., Transparency Tweaked in 2011
Executive Briefing Series
Efforts to secure the global drug supply chain were a key FDA concern in 2011, with the agency urging drugmakers to tighten supplier controls and aim high in their audits of foreign contractors.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing